COWAN-DISSERTATION-2020.Pdf (5.364Mb)

Total Page:16

File Type:pdf, Size:1020Kb

COWAN-DISSERTATION-2020.Pdf (5.364Mb) INVESTIGATION OF THE SUBCLINICAL TOXICOLOGICAL EFFECTS OF ERGOT ALKALOID MYCOTOXIN (Claviceps purpurea) EXPOSURE IN BEEF COWS AND BULLS A Thesis Submitted to the College of Graduate and Postdoctoral Studies In Partial Fulfillment of the Requirements For the Degree of Doctor of Philosophy In the Toxicology Graduate Program University of Saskatchewan Saskatoon By Vanessa Elizabeth Cowan © Copyright Vanessa Elizabeth Cowan, August 2020. All rights reserved i PERMISSION TO USE In presenting this thesis/dissertation in partial fulfillment of the requirements for a Postgraduate degree from the University of Saskatchewan, I agree that the Libraries of this University may make it freely available for inspection. I further agree that permission for copying of this thesis/dissertation in any manner, in whole or in part, for scholarly purposes may be granted by the professor or professors who supervised my thesis/dissertation work or, in their absence, by the Head of the Department or the Dean of the College in which my thesis work was done. It is understood that any copying or publication or use of this thesis/dissertation or parts thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition shall be given to me and to the University of Saskatchewan in any scholarly use which may be made of any material in my thesis/dissertation. Requests for permission to copy or to make other uses of materials in this thesis/dissertation in whole or part should be addressed to: Chair of the Toxicology Graduate Program 44 Campus Drive University of Saskatchewan Saskatoon, Saskatchewan S7N5B3 Canada OR Dean College of Graduate and Postdoctoral Studies University of Saskatchewan 116 Thorvaldson Building, 110 Science Place Saskatoon, Saskatchewan S7N5C9 Canada i ABSTRACT In my dissertation, I examine the effects of ergot alkaloid mycotoxins on vascular and reproductive systems in beef cows and bulls. Ergot alkaloids are toxic secondary metabolites produced by the pathogenic plant fungus Claviceps purpurea. Ergot alkaloids are commonly occurring adulterating toxins in livestock feed and constitute a great concern for the health of animals that consume such feeds. Consumption of these toxins can cause a broad suite of pathophysiological effects. Relevant and up-to-date scientific information on ergotism in livestock is largely unavailable to address this growing issue. The purpose of this research was to better characterize and understand the effects of ergot alkaloids in Canadian beef cattle and to ascertain concentrations at which these effects may occur. In my first two chapters, beef cows were fed increasing concentrations of ergot alkaloids over a short-term (Chapter 2) and long-term (Chapter 3) basis. As ergot alkaloids have a well- known vasoactive effect, hemodynamics of different arteries were evaluated with ultrasonography (B-mode and Doppler). In both studies, concentration-dependent, subclinical physiological changes in hemodynamics were observed in the caudal artery. These results are significant as a common end-stage manifestation of ergot alkaloid mycotoxicosis is the ischemic necrosis of the tail of exposed cattle. Further, these results indicate that subclinical changes occur at concentrations below current Canadian permissible values. Therefore, vascular changes appear to be the more sensitive indicator of ergot exposure than plasma prolactin changes in cows. Plasma or serum prolactin concentration is an accepted biomarker of ergot alkaloid exposure in livestock. To address the lack of pharmacokinetic information available on ergot alkaloids in cattle, I conducted two oral pharmacokinetics studies and attempted to develop an analytical method to detect ergot alkaloids in bovine plasma (Chapter 4). Although the method was promising for spiked plasma, ergot alkaloids were not detected in plasma samples collected from ergot-exposed cows. Likely, low oral bioavailability explained the lack of detection of ergot alkaloids in plasma from ergot-exposed cattle. An important practical conclusion of this work is that blood samples from suspected poisoning cases will not be clinically useful. In my last research chapter (Chapter 5), adult beef bulls were fed diets containing ergot alkaloids for one spermatogenic cycle (i.e., 61 days) to assess the potential negative effects of ergot exposure on sperm production or function. Results of this study indicated that ergot ii exposure had, at most, a subtle effect on bull sperm endpoints. However, plasma prolactin was affected by treatment. Spermatogenesis is not a sensitive endpoint for ergot exposure in adult bulls. Overall, this work answered questions related to ergot alkaloid exposure that are practically important. This work will enable policy makers to make scientifically-based decisions on guidelines for ergot alkaloids in cattle feed; will bolster the working knowledge of clinicians diagnosing and treating ergot-exposed cattle in the field; and will provide the much sought after information for producers working with ergot-contaminated grain or ergot exposed animals. iii ACKNOWLEDGEMENTS I gratefully acknowledge the guidance and mentorship received from my supervisors throughout my doctorate, Dr. Barry Blakley and Dr. Jaswant Singh. In addition, I acknowledge the assistance and support received from the members of my Advisory Committee: Dr. Mark Wickstrom, Dr. Jane Alcorn, Dr. Muhammed Anzar, and Dr. John McKinnon. I would also like to thank Dr. Lynn Weber, Chair of the Toxicology Graduate Program, and Dr. Gillian Muir, Department Head of Veterinary Biomedical Sciences, for their support. In addition, thank you to Dr. Tim Evans for serving as the external examiner for my dissertation defense. The research described in this dissertation was carried out with the support from the Government of Saskatchewan Agriculture Development Fund (#20130258 and #20160104) and the Saskatchewan Cattlemen’s Association (U of S Fund # 419027). This research was also supported by Dr. Singh’s NSERC Discovery Grant and in-kind contributions from Prairie Diagnostic Services. I was personally supported by the Natural Science of Engineering Research Council Canada Graduate Scholarship (at both the Master and Doctoral levels), the University of Saskatchewan Dean’s Scholarship, the Saskatchewan Innovation and Opportunity Scholarship, and the Toxicology Centre Devolved Scholarship. iv DEDICATION I happily dedicate this dissertation to my family and friends for their unwavering support throughout my degree program. I would especially like to dedicate this thesis to my grandparents, Myrt and (late) Bill Ryhorchuk, my mother, Christina Cowan, and my twin sister, Victoria Cowan. Thank you to my toxicology friends (Jen Briens, Dayna Schultz, Bryanna Eisner, and Shannon Bray) for the fun times and support throughout the grind. Thank you to my Brazilian jiu-jitsu friends and teammates (Shar Cairns and Jane Bryson) for letting me take my school stresses out on them on the mats. Thank you to Charlie Swain, Lianne Price, Chandler Giasson, Erin Matthews, Brad Campbell, Nick Charpentier, Cheryl Cho, and Alicia Unger for being steadfast friends and supports throughout it all. This thesis would not have been possible without the support and guidance of Dr. Barry Blakley. The gratitude I feel for Barry’s support over the years cannot be adequately expressed with words. I first started working for Barry in 2013 as a research assistant in Prairie Diagnostic Services. This is where I first introduced to analysis of ergot alkaloids in livestock feed. Barry and I were able to collaborate on four peer-reviewed manuscripts based on diagnostic case records in toxicology from Prairie Diagnostic Services. These publications undoubtedly helped me win scholarships and recognitions during my degree. In addition to his role my academic career, Barry also has also given me hours of his personal time. In 2014, he spent a day with me helping me purchase a car and set up my car insurance. In 2016, Barry hosted myself and my two friends from Germany at his cabin in Northern Saskatchewan for a day so they could have a new experience while they were in Canada. In 2018, he introduced me to the building manager at his daughter’s condominium complex which enabled me to rent an apartment from that complex. Thank you for everything you have done for me, Barry. I hope that I can make you proud in my career as a toxicologist. v TABLE OF CONTENTS Permission to Use............................................................................................................................i Abstract..........................................................................................................................................ii Acknowledgements.......................................................................................................................iv Dedication.......................................................................................................................................v List of tables................................................................................................................................xiv List of figures............................................................................................................................xviii Abbreviations..............................................................................................................................xxi 1. CHAPTER 1 – GENERAL INTRODUCTION......................................................................1
Recommended publications
  • Determination of Sex 43, Elm Park Gardens, THOSE Who Are Interested in the Heredity of Sex Chelsea, S.W.Lo
    APRIL 14, 1934 NATURE 579 sa was correctly computed in five minutes, 510 in genes outweigh the female and the result is the twenty seconds and 610 in seventy seconds. normal haplo-X male." Division was a slower process and 9 digits divided Thus, as my italics show, the experimental by 3 took times varying from two and a half to geneticist seems to agree with what Prof. MacBride seven and three quarters minutes. has expressed in more generally intelligible language ; Square roots of 6 digit numbers were extracted in not only in admitting the essential sameness of sex less than a minute while cube roots took longer. in all organisms but also in understanding the Curiously enough, the memorising of a number of function of proportion in its determination in some 27 digits was not done successfully, although he of them. Unanimity among the different branches of could repeat questions which had been put to him biology has therefore been reached after a long period and their answers after some days had elapsed, and of divergence, from entirely different data and, what would break off calculations in the middle to ask for is more, apparently unawares. Such an event, surely, milk or cigarettes, taking up the calculations again should not be allowed to pass without notice and where he had broken off. His methods of working without applause. The usual view that the chromo­ were not discovered, but he had obviously memorised some theory of sex determination criticised by the squares of two digit numbers, and less completely MacBride was a special hypothesis put forward by the products of two digit numbers.
    [Show full text]
  • Headshop Highs & Lows
    HeadshopHeadshop HighsHighs && LowsLows AA PresentationPresentation byby DrDr DesDes CorriganCorrigan HeadshopsHeadshops A.K.A.A.K.A. ““SmartSmart ShopsShops””,, ““HempHemp ShopsShops””,, ““HemporiaHemporia”” oror ““GrowshopsGrowshops”” RetailRetail oror OnlineOnline OutletsOutlets sellingselling PsychoactivePsychoactive Plants,Plants, ‘‘LegalLegal’’ && ““HerbalHerbal”” HighsHighs asas wellwell asas DrugDrug ParaphernaliaParaphernalia includingincluding CannabisCannabis growinggrowing equipment.equipment. Headshops supply Cannabis Paraphernalia HeadshopsHeadshops && SkunkSkunk--typetype (( HighHigh Strength)Strength) CannabisCannabis 1.1. SaleSale ofof SkunkSkunk--typetype seedsseeds 2.2. AdviceAdvice onon SinsemillaSinsemilla TechniqueTechnique 3.3. SaleSale ofof HydroponicsHydroponics && IntenseIntense LightingLighting .. CannabisCannabis PotencyPotency expressedexpressed asas %% THCTHC ContentContent ¾¾ IrelandIreland ¾¾ HerbHerb 6%6% HashHash 4%4% ¾¾ UKUK ¾¾ HerbHerb** 1212--18%18% HashHash 3.4%3.4% ¾¾ NetherlandsNetherlands ¾¾ HerbHerb** 20%20% HashHash 37%37% * Skunk-type SkunkSkunk--TypeType CannabisCannabis && PsychosisPsychosis ¾¾ComparedCompared toto HashHash smokingsmoking controlscontrols ¾¾ SkunkSkunk useuse -- 77 xx riskrisk ¾¾ DailyDaily SkunkSkunk useuse -- 1212 xx riskrisk ¾¾ DiDi FortiForti etet alal .. Br.Br. J.J. PsychiatryPsychiatry 20092009 CannabinoidsCannabinoids ¾¾ PhytoCannabinoidsPhytoCannabinoids-- onlyonly inin CannabisCannabis plantsplants ¾¾ EndocannabinoidsEndocannabinoids –– naturallynaturally occurringoccurring
    [Show full text]
  • Endophytic Fungi: Treasure for Anti-Cancerous Compounds
    International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 8, Issue 8, 2016 Review Article ENDOPHYTIC FUNGI: TREASURE FOR ANTI-CANCEROUS COMPOUNDS ANAND DILIP FIRODIYAa*, RAJESH KUMAR TENGURIAb aCSRD, Peoples University, Bhopal 462037, Madhya Pradesh, India, bDepartment of Botany, Govt. PG College, Rajgarh 496551, Madhya Pradesh, India Email: [email protected] Received: 22 Apr 2016 Revised and Accepted: 20 June 2016 ABSTRACT Endophytic fungi that live asymptomatically inside the plant tissues have novel bioactive metabolites exhibiting a variety of biological activities, especially against cancer. This review highlights the research progress on the production of anticancer compounds by endophytic fungi from 1990- 2015. Anticancer activity is generally associated with the cytotoxicity of the compounds present in the endophytic fungi. The ubiquitous nature of endophytic fungi synthesise diverse chemicals with promising anticancer activity from either their original host or related species. Modification in fermentation parameters and genetic insight of endophytes may produce novel anti-cancerous compounds. Keywords: Cancer, Medicinal plants, Secondary metabolites © 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) INTRODUCTION endophytic fungi detectable by high-performance liquid chromate- graphy, nuclear magnetic resonance, mass spectrophotometer and The interest in the biogenic medicines has revived throughout the X-ray crystallography and its cytotoxicity of the bioactive world, as the increase in awareness of the health hazards and compounds against cancer cell lines. The compounds with potential toxicity associated with the random use of synthetic drugs and application were also considered in the selection of antitumor antibiotics [1].
    [Show full text]
  • Cabergoline Patient Handout
    Cabergoline For the Patient: Cabergoline Other names: DOSTINEX® • Cabergoline (ca-BERG-go-leen) is used to treat cancers that cause the body to produce too much of a hormone called prolactin. Cabergoline helps decrease the size of the cancer and the production of prolactin. It is a tablet that you take by mouth. • Tell your doctor if you have ever had an unusual or allergic reaction to bromocriptine or other ergot derivatives, such as pergoline (PERMAX®) and methysergide (SANSERT®), before taking cabergoline. • Blood tests and blood pressure measurement may be taken while you are taking cabergoline. The dose of cabergoline may be changed based on the test results and/or other side effects. • It is important to take cabergoline exactly as directed by your doctor. Make sure you understand the directions. Take cabergoline with food. • If you miss a dose of cabergoline, take it as soon as you can if it is within 2 days of the missed dose. If it is over 2 days since your missed dose, skip the missed dose and go back to your usual dosing times. • Other drugs such as azithromycin (ZITHROMAX®), clarithromycin (BIAXIN®), erythromycin, domperidone, metoclopramide, and some drugs used to treat mental or mood problems may interact with cabergoline. Tell your doctor if you are taking these or any other drugs as you may need extra blood tests or your dose may need to be changed. Check with your doctor or pharmacist before you start or stop taking any other drugs. • The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of cabergoline.
    [Show full text]
  • Hallucinogens: a Cause of Convulsive Ergot Psychoses
    Loma Linda University TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works Loma Linda University Electronic Theses, Dissertations & Projects 6-1976 Hallucinogens: a Cause of Convulsive Ergot Psychoses Sylvia Dahl Winters Follow this and additional works at: https://scholarsrepository.llu.edu/etd Part of the Psychiatry Commons Recommended Citation Winters, Sylvia Dahl, "Hallucinogens: a Cause of Convulsive Ergot Psychoses" (1976). Loma Linda University Electronic Theses, Dissertations & Projects. 976. https://scholarsrepository.llu.edu/etd/976 This Thesis is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. It has been accepted for inclusion in Loma Linda University Electronic Theses, Dissertations & Projects by an authorized administrator of TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. For more information, please contact [email protected]. ABSTRACT HALLUCINOGENS: A CAUSE OF CONVULSIVE ERGOT PSYCHOSES By Sylvia Dahl Winters Ergotism with vasoconstriction and gangrene has been reported through the centuries. Less well publicized are the cases of psychoses associated with convulsive ergotism. Lysergic acid amide a powerful hallucinogen having one.-tenth the hallucinogenic activity of LSD-25 is produced by natural sources. This article attempts to show that convulsive ergot psychoses are mixed psychoses caused by lysergic acid amide or similar hallucinogens combined with nervous system
    [Show full text]
  • Biased Ligands Differentially Shape the Conformation of The
    International Journal of Molecular Sciences Article Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT2B Receptors Katrin Denzinger, Trung Ngoc Nguyen, Theresa Noonan, Gerhard Wolber and Marcel Bermudez * Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2-4, 14195 Berlin, Germany; [email protected] (K.D.); [email protected] (T.N.N.); [email protected] (T.N.); [email protected] (G.W.) * Correspondence: [email protected] Received: 22 November 2020; Accepted: 18 December 2020; Published: 20 December 2020 Abstract: G protein-coupled receptors are linked to various intracellular transducers, each pathway associated with different physiological effects. Biased ligands, capable of activating one pathway over another, are gaining attention for their therapeutic potential, as they could selectively activate beneficial pathways whilst avoiding those responsible for adverse effects. We performed molecular dynamics simulations with known β-arrestin-biased ligands like lysergic acid diethylamide and ergotamine in complex with the 5-HT2B receptor and discovered that the extent of ligand bias is directly connected with the degree of closure of the extracellular loop region. Given a loose allosteric coupling of extracellular and intracellular receptor regions, we delineate a concept for biased signaling at serotonin receptors, by which conformational interference with binding pocket closure restricts the signaling repertoire of the receptor. Molecular docking studies of biased ligands gathered from the BiasDB demonstrate that larger ligands only show plausible docking poses in the ergotamine-bound structure, highlighting the conformational constraints associated with bias. This emphasizes the importance of selecting the appropriate receptor conformation on which to base virtual screening workflows in structure-based drug design of biased ligands.
    [Show full text]
  • WO 2010/099522 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 2 September 2010 (02.09.2010) WO 2010/099522 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 45/06 (2006.01) A61K 31/4164 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/4045 (2006.01) A61K 31/00 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2010/025725 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 1 March 2010 (01 .03.2010) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/156,129 27 February 2009 (27.02.2009) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, HELSINN THERAPEUTICS (U.S.), INC.
    [Show full text]
  • Spatial Patterns of Claviceps Purpurea in Kentucky Bluegrass And
    SPATIAL PATTERNS OF CLAVICEPS PURPUREA IN KENTUCKY BLUEGRASS AND PERENNIAL RYEGRASS GROWN FOR SEED AND EFFECT OF SOIL-APPLIED FUNGICIDES ON GERMINATION OF ERGOT SCLEROTIA J.K.S. Dung, D.L. Walenta, S.C. Alderman, and P.B. Hamm Introduction protective fungicide applications are required during Ergot, caused by the fungus Claviceps purpurea, is anthesis. Some growers experience severe ergot an important floral disease of grasses that issues even after four fungicide applications. A significantly impacts Kentucky bluegrass (KBG) and limited number of fungicides are currently available perennial ryegrass (PRG) seed production in the and new products or application strategies need to be Pacific Northwest (PNW). The fungus infects evaluated. In addition to timing fungicides during unfertilized ovaries and replaces seed with elongated anthesis, when flowers are susceptible to infection, it black fungal bodies called sclerotia, which may be possible to apply fungicides to sclerotia in overwinter in the soil and germinate to produce the field during the fall and/or as they begin to airborne ascospores in the spring. In addition to germinate in the spring before they release spores. yield losses from ergot, the repeated cleanings Soil-applied fungicides may reduce sclerotia required to remove ergot sclerotia to achieve seed germination and spore production, limiting the certification standards result in additional seed loss production of primary inoculum and subsequent as well as extra costs in time and labor. ergot infection (Hardison 1975). Although ergot is a persistent problem in PNW grass The objectives of this study were to: 1) quantify and seed production, the incidence and intensity of ergot describe the spatial patterns of ergot epidemics in epidemics can vary regionally, locally, and from commercial KBG and PRG fields in Oregon and year to year.
    [Show full text]
  • Risk Assessment of Argyreia Nervosa
    Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos RIVM letter report 2019-0210 Colophon © RIVM 2020 Parts of this publication may be reproduced, provided acknowledgement is given to the: National Institute for Public Health and the Environment, and the title and year of publication are cited. DOI 10.21945/RIVM-2019-0210 W. Chen (author), RIVM L. de Wit-Bos (author), RIVM Contact: Lianne de Wit Department of Food Safety (VVH) [email protected] This investigation was performed by order of NVWA, within the framework of 9.4.46 Published by: National Institute for Public Health and the Environment, RIVM P.O. Box1 | 3720 BA Bilthoven The Netherlands www.rivm.nl/en Page 2 of 42 RIVM letter report 2019-0210 Synopsis Risk assessment of Argyreia nervosa In the Netherlands, seeds from the plant Hawaiian Baby Woodrose (Argyreia nervosa) are being sold as a so-called ‘legal high’ in smart shops and by internet retailers. The use of these seeds is unsafe. They can cause hallucinogenic effects, nausea, vomiting, elevated heart rate, elevated blood pressure, (severe) fatigue and lethargy. These health effects can occur even when the seeds are consumed at the recommended dose. This is the conclusion of a risk assessment performed by RIVM. Hawaiian Baby Woodrose seeds are sold as raw seeds or in capsules. The raw seeds can be eaten as such, or after being crushed and dissolved in liquid (generally hot water).
    [Show full text]
  • United States Patent (19) [11] 3,968,111 Bach Et Al
    United States Patent (19) [11] 3,968,111 Bach et al. (45) July 6, 1976 54 8,8-DISUBSTITUTED-6- 3,113,133 12/1963 Hofmann et al..w. 260/285.5 METHYLERGOLINES AND RELATED COMPOUNDS Primary Examiner-Alton D. Rollins 75) inventors: Nicholas J. Bach; Edmund C. Assistant Examiner-Mary Vaughn Kornfeld, both of Indianapolis, Ind. Attorney, Agent, or Firm-James L. Rowe, Everet F. 73) Assignee: Eli Lilly and Company, Indianapolis, Smith Ind. 22 Filed: Dec. 6, 1974 21 Appl. No.: 530,320 57 ABSTRACT 8,8-Disubstituted-6-methylergolines and 9-ergolenes, 52 U.S. Cl............................... 260/285.5; 424/261 prepared by alkylation of lysergic, isolysergic or their 51 int. C.’................ C07D 457/02; C07D 457/10 9,10-dihydro analogues, optionally followed by chemi 58) Field of Search.................................. 260/285.5 cal modification of an 8-substituent. 56 References Cited UNITED STATES PATENTS 9 Claims, No Drawings 2,86,074 1 1/1958 Kornfeld et al.................. 260/285.5 3,968, 111 1 2 1722 (1957) prepared the 8-methyl derivative of D-iso 8,8-DISUBSTITUTED-6-METHYLERGOLINES AND lysergic acid diethylamide, stating that they were, how RELATED COMPOUNDS ever, unable to obtain substitution at C8 using dihydro lysergic acid methyl ester and the alkylating agent used BACKGROUND OF THE INVENTION successfully with lysergic acid itself; to wit, methylio Compounds based on the ergoline ring system dide and potassium amide. These authors also prepared 8-ethyl-D-isolysergic acid diethylamide and the 1,8- dimethyl-D-isolysergic acid diethylamide. There is no mention in the literature of an 8,8-disubstituted-9-ergo O lene in which the substituents at 8 are other than amide groups and in which the 1-position is not substituted.
    [Show full text]
  • USP Reference Standards Catalog
    Last Updated On: January 6, 2016 USP Reference Standards Catalog Catalog # Description Current Lot Previous Lot CAS # NDC # Unit Price Special Restriction 1000408 Abacavir Sulfate R028L0 F1L487 (12/16) 188062-50-2 $222.00 (200 mg) 1000419 Abacavir Sulfate F0G248 188062-50-2 $692.00 Racemic (20 mg) (4-[2-amino-6-(cyclo propylamino)-9H-pur in-9yl]-2-cyclopenten e-1-methanol sulfate (2:1)) 1000420 Abacavir Related F1L311 F0H284 (10/13) 124752-25-6 $692.00 Compound A (20 mg) ([4-(2,6-diamino-9H- purin-9-yl)cyclopent- 2-enyl]methanol) 1000437 Abacavir Related F0M143 N/A $692.00 Compound D (20 mg) (N6-Cyclopropyl-9-{( 1R,4S)-4-[(2,5-diami no-6-chlorpyrimidin- 4-yloxy)methyl] cyclopent-2-enyl}-9H -purine-2,6-diamine) 1000441 Abacavir Related F1L318 F0H283 (10/13) N/A $692.00 Compound B (20 mg) ([4-(2,5-diamino-6-c Page 1 Last Updated On: January 6, 2016 USP Reference Standards Catalog Catalog # Description Current Lot Previous Lot CAS # NDC # Unit Price Special Restriction hloropyrimidin-4-yla mino)cyclopent-2-en yl]methanol) 1000452 Abacavir Related F1L322 F0H285 (09/13) 172015-79-1 $692.00 Compound C (20 mg) ([(1S,4R)-4-(2-amino -6-chloro-9H-purin-9 -yl)cyclopent-2-enyl] methanol hydrochloride) 1000485 Abacavir Related R039P0 F0J094 (11/16) N/A $692.00 Compounds Mixture (15 mg) 1000496 Abacavir F0J102 N/A $692.00 Stereoisomers Mixture (15 mg) 1000500 Abacavir System F0J097 N/A $692.00 Suitability Mixture (15 mg) 1000521 Acarbose (200 mg) F0M160 56180-94-0 $222.00 (COLD SHIPMENT REQUIRED) 1000532 Acarbose System F0L204 N/A $692.00 Suitability
    [Show full text]
  • Male Anorgasmia: from “No” to “Go!”
    Male Anorgasmia: From “No” to “Go!” Alexander W. Pastuszak, MD, PhD Assistant Professor Center for Reproductive Medicine Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Disclosures • Endo – speaker, consultant, advisor • Boston Scientific / AMS – consultant • Woven Health – founder, CMO Objectives • Understand what delayed ejaculation (DE) and anorgasmia are • Review the anatomy and physiology relevant to these conditions • Review what is known about the causes of DE and anorgasmia • Discuss management of DE and anorgasmia Definitions Delayed Ejaculation (DE) / Anorgasmia • The persistent or recurrent delay, difficulty, or absence of orgasm after sufficient sexual stimulation that causes personal distress Intravaginal Ejaculatory Latency Time (IELT) • Normal (median) à 5.4 minutes (0.55-44.1 minutes) • DE à mean IELT + 2 SD = 25 minutes • Incidence à 2-11% • Depends in part on definition used J Sex Med. 2005; 2: 492. Int J Impot Res. 2012; 24: 131. Ejaculation • Separate event from erection! • Thus, can occur in the ABSENCE of erection! Periurethral muscle Sensory input - glans (S2-4) contraction Emission Vas deferens contraction Sympathetic input (T12-L1) SV, prostate contraction Bladder neck contraction Expulsion Bulbocavernosus / Somatic input (S1-3) spongiosus contraction Projectile ejaculation J Sex Med. 2011; 8 (Suppl 4): 310. Neurochemistry Sexual Response Areas of the Brain • Pons • Nucleus paragigantocellularis Neurochemicals • Norepinephrine, serotonin: • Inhibit libido,
    [Show full text]